CN102631677A - 一种预防和/或治疗动脉粥样硬化的药物组合物 - Google Patents
一种预防和/或治疗动脉粥样硬化的药物组合物 Download PDFInfo
- Publication number
- CN102631677A CN102631677A CN2012101166255A CN201210116625A CN102631677A CN 102631677 A CN102631677 A CN 102631677A CN 2012101166255 A CN2012101166255 A CN 2012101166255A CN 201210116625 A CN201210116625 A CN 201210116625A CN 102631677 A CN102631677 A CN 102631677A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- androgen
- estrogen
- dht
- dihydrotestosterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101166255A CN102631677A (zh) | 2012-04-19 | 2012-04-19 | 一种预防和/或治疗动脉粥样硬化的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012101166255A CN102631677A (zh) | 2012-04-19 | 2012-04-19 | 一种预防和/或治疗动脉粥样硬化的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102631677A true CN102631677A (zh) | 2012-08-15 |
Family
ID=46616360
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012101166255A Pending CN102631677A (zh) | 2012-04-19 | 2012-04-19 | 一种预防和/或治疗动脉粥样硬化的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102631677A (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1312718A (zh) * | 1998-06-11 | 2001-09-12 | 内部研究股份有限公司 | 与脱氢表雄酮或类似物组合的选择性雌激素受体调节剂 |
CN1400904A (zh) * | 2000-01-28 | 2003-03-05 | 恩多研究公司 | 与雌激素联合的选择性雌激素受体调节剂 |
CN101444519A (zh) * | 1993-01-19 | 2009-06-03 | 恩多研究公司 | 脱氢表雄酮的治疗用途和传送系统 |
-
2012
- 2012-04-19 CN CN2012101166255A patent/CN102631677A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444519A (zh) * | 1993-01-19 | 2009-06-03 | 恩多研究公司 | 脱氢表雄酮的治疗用途和传送系统 |
CN1312718A (zh) * | 1998-06-11 | 2001-09-12 | 内部研究股份有限公司 | 与脱氢表雄酮或类似物组合的选择性雌激素受体调节剂 |
CN1400904A (zh) * | 2000-01-28 | 2003-03-05 | 恩多研究公司 | 与雌激素联合的选择性雌激素受体调节剂 |
Non-Patent Citations (2)
Title |
---|
BIRGIT BRUCK等: "Gender-Specific Differences in the Effects of Testosterone and Estrogen on the Development of Atherosclerosis in Rabbits", 《ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY》 * |
JEREMIAH STAMLER等: "Prevention of Coronary Atherosclerosis by Estrogen-Androgen Administration in the Cholesterol-Fed Chick", 《CIRCULATION RESEARCH》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Iglesias et al. | Gonadal dysfunction in men with chronic kidney disease: clinical features, prognostic implications and therapeutic options | |
Schleich et al. | Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male | |
US11160813B2 (en) | Combination therapy for nonalcoholic steatohepatitis (NASH) and liver fibrosis | |
GELLER et al. | Medical castration of males with megestrol acetate and small doses of diethylstilbestrol | |
Eberle et al. | Treatment of persistent pubertal gynecomastia with dihydrotestosterone heptanoate | |
US20080207769A1 (en) | Method for treating benign prostatic hyperplasia | |
Callow et al. | The effect of the administration of testosterone propionate on the urinary excretion of compounds allied to the steroid hormones | |
EP4234015A2 (fr) | Procédés de traitement d'une déficience en testostérone | |
JP2009035559A (ja) | 良性前立腺肥大の治療のためのビタミンd3アナログの使用 | |
Landais et al. | A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosis | |
Stubbe Østergaard et al. | Hay fever and a single intramuscular injection of corticosteroid: a systematic review | |
US20080262071A1 (en) | Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder | |
Carter et al. | Effect of oral contraceptives on plasma clearance | |
Casson et al. | DHEA administration to humans: panacea or palaver? | |
CN102631677A (zh) | 一种预防和/或治疗动脉粥样硬化的药物组合物 | |
CN103536922B (zh) | 酰基辅酶a:胆固醇酰基转移酶‑2抑制剂在抑制肝癌生长中的应用 | |
Wu | Hormonal approaches to male contraception: approaching reality | |
Balasubramanian et al. | DHEA: The remedy for andropause | |
Meriggiola et al. | Recent advances in hormonal male contraception | |
JP2015533150A (ja) | 前立腺がんの根治的又は対症的処置における使用のためのホスフェストロール | |
Liu et al. | Androgen therapy in non-gonadal disease | |
Costa et al. | Face-sparing congenital generalized lipodystrophy type 1 associated with nonclassical congenital adrenal hyperplasia | |
Segre et al. | Effects of epinephrine on the production and metabolic clearance of cortisol in normal men and women and in women with idiopathic hirsutism | |
Huhtaniemi | A hormonal contraceptive for men: how close are we? | |
EP1793818A2 (fr) | Pindolol pour le traitement du syndrome et du trouble dysphorique premenstruel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120815 |